Improvement of recurrence-free survival after radical prostatectomy for locally advanced prostate cancer in relation to the time of surgical intervention

Objective: to comparatively estimate the frequency of a positive surgical margin and 5-year biochemical recurrent-free survival (BRFS) rates in patients with locally advanced prostate cancer in relation to the time of radical retropubic prostatectomy.

Subjects and methods. The investigation enrolled 274 patients with prostate cancer (pT3-4N0-1M0) who were divided into 2 groups of 68 and 20 patients operated on in 1997 to 2006 and 2007 to 2012, respectively. Two surgeons made surgical interventions by the standardized procedure. The 5-year BRFS rates were estimated using the Kaplan-Meier method and log-rank test. A biochemical recurrence was defined as a prostatespecific antigen level of t 0.2 ng / ml in 2 consecutive measurements or as the initiation of adjuvant therapy.

Results. The detection rate of a positive surgical margin decreased from 55.9 % in 1997–2006 to 37.9 % in 2007–2012 (p = 0.01); the 5-year recurrence-free survival rates were 38.8 % versus 66.2 % (p < 0.001).

Conclusion. These changes would probably be a result of surgeons» better experience and improved surgical techniques in the course of time.

1. Heidenreich A., Bastian P.J., Bellmunt J. et al. EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 2014;65(1):124–37.

2. Mitchell R.E.I, Shah J.B., Olsson C.A. et al. Does year of radical prostatectomy independently predict outcome in prostate cancer? Urology. 2006;67(2): 368–72.

3. Kulkarni J.N., Singh D.P., Bansal S. et al. Retropubic radical prostatectomy: Clinicopathological observations and outcome analysis of 428 consecutive patients. Indian J Urol 2011;27(3):337–44.

4. Desireddi N.V., Roehl K.A., Loeb S. et al. Improved stage and grade-specific progressionfree survival rates after radical prostatectomy in the PSA era. Urology 2007;70(5): 950–5.

5. Faria E.F., Chapin B.F., Muller L.R. et al. Radical prostatectomy for locally advanced prostate cancer: current status. Urology 2015;86(1):10–5.

6. Sooriakumaran P., Nyberg T., Akre O. et al. Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes. BMJ 2014;26:348:1502.

7. Surcel C.L., Sooriakumaran P., Briganti A. et al. Preferences in the management of highrisk prostate cancer among urologists in Europe: results of a web-based survey. BJU Int 2015;115(4):571–9.

8. Mitchell C.R., Boorjian S.A., Umbreit E.C. et al. 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer. BJU Int 2012;110(11):1709–13.

9. Mullins J.K., Feng Z., Trock B.J. et al. The impact of anatomical radical retropubic prostatectomy on cancer control: The 30-year anniversary. J Urol 2012;188: 2219–24.

10. Fairey A.S., Daneshmand S., Skinner E.C. et al. Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era. Urol Oncol 2014;32(2):85–91.

11. Park J., Yoo D.S., Song C. et al. Comparison of oncological outcomes between retropubic radical prostatectomy and robot- assisted radical prostatectomy: an analysis stratified by surgical experience. World J Urol 2014;32(1):193–9.

12. Hartz A., He T., Strope S. et al. Surgeon variation in patient quality of life after radical prostatectomy. J Urol 2013;189(4):1295–301.